Pirtobrutinib and BTK Inhibitors in the CLL Treatment Landscape
Pharmacy Times,
Image credit: jarun011 | stock.adobe.com Précis This review discusses the prevalence, mechanisms of development, and evolving…
Image credit: jarun011 | stock.adobe.com Précis This review discusses the prevalence, mechanisms of development, and evolving…
Dive Brief: The Food and Drug Administration told Merck KGaA not to give an experimental drug for multiple sclerosis to new…
Summary Overview of Curis, including key partnerships, balance sheet, and recent stock price.
Patients with chronic lymphocytic leukemia (CLL) who received treatment with single-agent acalabrutinib (Calquence) experienced…